Thrivent Financial for Lutherans’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-59,191
| Closed | -$5.03M | – | 2330 |
|
|
2019
Q4 | $5.03M | Buy |
59,191
+557
| +0.9% | +$37.1K | 0.01% | 729 |
|
|
2019
Q3 | $2.93M | Buy |
58,634
+4,064
| +7% | +$162K | 0.01% | 824 |
|
|
2019
Q2 | $1.99M | Buy |
54,570
+4,303
| +9% | +$140K | 0.01% | 1003 |
|
|
2019
Q1 | $1.41M | Buy |
50,267
+3,880
| +8% | +$91.4K | ﹤0.01% | 1146 |
|
|
2018
Q4 | $888K | Buy |
46,387
+1,020
| +2% | +$23.7K | ﹤0.01% | 1232 |
|
|
2018
Q3 | $1.36M | Buy |
45,367
+930
| +2% | +$35K | ﹤0.01% | 1100 |
|
|
2018
Q2 | $1.63M | Buy |
44,437
+1,027
| +2% | +$33.4K | 0.01% | 995 |
|
|
2018
Q1 | $1.43M | Buy |
43,410
+3,911
| +10% | +$122K | ﹤0.01% | 1048 |
|
|
2017
Q4 | $1.08M | Buy |
39,499
+779
| +2% | +$24K | ﹤0.01% | 1206 |
|
|
2017
Q3 | $1.43M | Sell |
38,720
-4,890
| -11% | -$180K | 0.01% | 992 |
|
|
2017
Q2 | $1.66M | Buy |
43,610
+5,490
| +14% | +$245K | 0.01% | 890 |
|
|
2017
Q1 | $1.86M | Buy |
38,120
+320
| +0.8% | +$14.6K | 0.01% | 870 |
|
|
2016
Q4 | $1.28M | Buy |
37,800
+2,130
| +6% | +$75.5K | 0.01% | 1029 |
|
|
2016
Q3 | $1.35M | Buy |
35,670
+1,490
| +4% | +$56.2K | 0.01% | 1010 |
|
|
2016
Q2 | $1.15M | Buy |
34,180
+2,120
| +7% | +$74.7K | 0.01% | 1044 |
|
|
2016
Q1 | $1.02M | Buy |
32,060
+2,310
| +8% | +$75.4K | ﹤0.01% | 1071 |
|
|
2015
Q4 | $1.11M | Buy |
29,750
+1,750
| +6% | +$66.1K | 0.01% | 1035 |
|
|
2015
Q3 | $1.06M | Buy |
28,000
+2,300
| +9% | +$80.7K | 0.01% | 949 |
|
|
2015
Q2 | $735K | Buy |
25,700
+1,400
| +6% | +$39K | ﹤0.01% | 932 |
|
|
2015
Q1 | $681K | Buy |
24,300
+500
| +2% | +$14K | ﹤0.01% | 977 |
|
|
2014
Q4 | $659K | Sell |
23,800
-135,750
| -85% | -$3.36M | ﹤0.01% | 981 |
|
|
2014
Q3 | $3.56M | Sell |
159,550
-33,800
| -17% | -$858K | 0.02% | 561 |
|
|
2014
Q2 | $5.62M | Buy |
193,350
+169,800
| +721% | +$4.53M | 0.03% | 464 |
|
|
2014
Q1 | $669K | Buy |
23,550
+250
| +1% | +$8.27K | ﹤0.01% | 839 |
|
|
2013
Q4 | $900K | Sell |
23,300
-62,600
| -73% | -$2.24M | 0.01% | 789 |
|
|
2013
Q3 | $2.88M | Sell |
85,900
-494,800
| -85% | -$15.8M | 0.02% | 527 |
|
|
2013
Q2 | $17.9K | Buy |
+580,700
| New | +$19.4M | 0.12% | 202 |
|
Other funds holding MDCO
Thrivent Financial for Lutherans's MDCO Position: Q1 2020 in Review
Thrivent Financial for Lutherans sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 59,191 shares — an estimated $5.03M sold.
Thrivent Financial for Lutherans first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $5.62M in Q2 2014. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Thrivent Financial for Lutherans reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 59,191 Medicines Co shares in Q1 2020, an estimated $5.03M.
- Thrivent Financial for Lutherans first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Thrivent Financial for Lutherans's Medicines Co position peaked at $5.62M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2020, filed 15 May 2020.